Correlation of baseline molecular and clinical variables with ALK inhibitor efficacy in ALTA-1L.

D. Ross Camidge,Huifeng Niu,Hye Ryun Kim,James Chih-Hsin Yang,Myung-Ju Ahn,Jacky Yu-Chung Li,Maximilian Hochmair,Angelo Delmonte,Alexander I. Spira,Rosario García-Campelo,Fabrice Barlesi,Geoffrey Liu,Marcello Tiseo,Cong Li,Miguel Williams,Hyunjin Shin,Pingkuan Zhang,Sanjay Popat

Correlation of baseline molecular and clinical variables with ALK inhibitor efficacy in ALTA-1L.

2020

D. Ross Camidge
Huifeng Niu
Hye Ryun Kim
James Chih-Hsin Yang
Myung-Ju Ahn
Jacky Yu-Chung Li
Maximilian Hochmair
Angelo Delmonte
Alexander I. Spira
Rosario García-Campelo
Fabrice Barlesi
Geoffrey Liu
Marcello Tiseo
Cong Li
Miguel Williams
Hyunjin Shin
Pingkuan Zhang
Sanjay Popat

9517Background: Efficacy of ALK TKIs in patients (pts) with ALK+ non-small cell lung cancer (NSCLC) varies. We evaluated the impact of EML4-ALK fusion variants and other baseline (BL) molecular and...

Keywords:

ALK inhibitor
Internal medicine
Oncology
clinical variables
Pathology
Medicine
Correlation

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations